C-type natriuretic peptide (CNP) and brain natriuretic peptide (BNP) a
re members of the natriuretic peptide family, which have been shown to
interact with ANP-C/ANF-R2 receptors in addition to ANP-B receptor su
btypes. The present study was undertaken to investigate if the interac
tion of CNP and BNP with ANP-C receptors results in the inhibition of
adenylyl cyclase activity. CNP and BNP inhibited adenylyl cyclase acti
vity in heart and brain striatal membranes in a concentration dependen
t manner with an apparent K-i between 0.1 and 1.0 nM. Maximal inhibiti
on observed in heart membranes were about 25% and 35% for BNP and CNP
respectively however the inhibitions in brain striatal membranes were
smaller ( similar to 20%). The inhibition was dependent on the presenc
e of guanine nucleotides and was attenuated by pertussis toxin treatme
nt, In addition, CNP inhibited the stimulatory effect of isoproterenol
on adenylyl cyclase, whereas CNP as well as BNP shelved an additive e
ffect with the inhibitory response of angiotensin II on adenylyl cycla
se activity, When the combined effect of C-ANF(4-23)/BNP, C-ANF(4-23)/
CNP and BNP/CNP at optimal concentrations was studied together on aden
ylyl cyclase activity, the percent inhibition remained the same for C-
ANF(4-23) and BNP or C-ANF(4-23) and CNP, however, an additive inhibit
ory effect was observed for BNP and CNP, These results suggest that CN
P and BNP like C-ANF(4-23), interact with ANP-C receptors and result i
n the inhibition of adenylyl cyclase activity, On the other hand, CNP
and BNP interact with the ANP-C receptor, however, the interaction may
be at different sites or there may be two subpopulations of ANP-C rec
eptors specific for each of the peptides, These results indicate that
BNP and CNP, like ANP and C-ANF(4-23), inhibit the adenylyl cyclase/cA
MP signal transduction system through an inhibitory guanine nucleotide
regulatory protein, by interacting with ANP-C receptor subtypes.